rediff.com
e.g. Tata motors, Reliance MF, 500570
Parabolic Drugs Ltd. - Research Center
533211 PARABDRUGS Group (Z) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 20 Mar ' 18 Mar ' 17 Mar ' 16 Mar ' 15
Sources of funds
Owner's fund
Equity share capital 61.89 61.89 61.89 61.89 61.89
Share application money - 26.00 26.00 26.00 26.00
Preference share capital - - - - -
Reserves & surplus -978.27 -934.22 -877.22 -769.15 -283.96
Loan funds
Secured loans 156.27 948.78 943.69 937.47 925.00
Unsecured loans - 35.33 35.78 34.28 32.49
Total -760.11 137.78 190.14 290.49 761.42
Uses of funds
Fixed assets
Gross block 283.44 480.39 482.00 482.74 485.35
Less : revaluation reserve - - - - -
Less : accumulated depreciation - 154.02 133.16 111.55 90.22
Net block 283.44 326.37 348.84 371.19 395.13
Capital work-in-progress - 6.52 6.52 6.52 6.52
Investments 6.34 6.34 6.33 6.33 6.32
Net current assets
Current assets, loans & advances 58.54 79.72 131.69 192.97 542.16
Less : current liabilities & provisions 1,108.43 281.16 303.24 286.51 188.72
Total net current assets -1,049.89 -201.45 -171.54 -93.55 353.45
Miscellaneous expenses not written - - - - -
Total -760.11 137.78 190.14 290.49 761.42
Notes:
Book value of unquoted investments - 6.34 6.33 6.33 6.32
Market value of quoted investments - - - - -
Contingent liabilities - 6.25 - - 8.33
Number of equity sharesoutstanding (Lacs) 618.90 618.92 618.92 618.92 618.92
Close
Add Parabolic Drugs Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Parabolic Drugs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close